1-4 of 4
Cynthia A. Pise-Masison
Close
Sort by
Journal Articles

Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia

Jing Chen, Cynthia A. Pise-Masison, Joanna H. Shih, John C. Morris, John E. Janik, Kevin C. Conlon, Anne Keating, Thomas A. Waldmann
Journal: Blood
Blood (2013) 121 (11): 2029–2037.
https://doi.org/10.1182/blood-2012-05-427773
Published: 2013
Includes: Supplemental data
Journal Articles

Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles

Vibeke Andresen, Cynthia A. Pise-Masison, Uma Sinha-Datta, Marcia Bellon, Valerio Valeri, Robyn Washington Parks, Valentina Cecchinato, Risaku Fukumoto, Christophe Nicot, Genoveffa Franchini
Journal: Blood
Blood (2011) 118 (6): 1549–1559.
https://doi.org/10.1182/blood-2010-06-293340
Published: 2011
Includes: Supplemental data
Journal Articles

Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability

Cynthia A. Pise-Masison, Michael Radonovich, Kathleen Dohoney, John C. Morris, Deirdre O'Mahony, Min-Jung Lee, Jane Trepel, Thomas A. Waldmann, John E. Janik, John N. Brady
Journal: Blood
Blood (2009) 113 (17): 4016–4026.
https://doi.org/10.1182/blood-2008-08-175901
Published: 2009
Includes: Supplemental data
Journal Articles

HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity

Soo-Jin Jeong, Michael Radonovich, John N. Brady, Cynthia A. Pise-Masison
Journal: Blood
Blood (2004) 104 (5): 1490–1497.
https://doi.org/10.1182/blood-2003-12-4174
Published: 2004